PETALING JAYA: Hong Seng Consolidated Bhd will be funding its 60% acquisition of Neogenix Laboratoire Sdn Bhd for RM6.5mil via a combination of internally generated funds and proceeds received from the conversion of irredeemable convertible preference shares (Iculs).
In a reply to a query from Bursa Malaysia yesterday, Hong Seng said RM500,000 would be funded through internally generated funds.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!